Verano Holdings (VRNO) Common Equity (2021 - 2026)

Verano Holdings' (VRNO) quarterly Common Equity came in at $688.3 million in Q1 2026, down 26.9% year-on-year from $941.6 million in Q1 2025, and down 2.25% on a QoQ basis from $704.2 million in Q4 2025.

Verano Holdings (VRNO) Common Equity (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Common Equity data on file, last reported at $688.3 million in Q1 2026.

  • On a quarterly basis, Common Equity fell 26.9% year-over-year to $688.3 million in Q1 2026; TTM through Mar 2026 was $688.3 million, a 26.9% decrease from a year earlier, with the FY2025 full-year figure at $704.2 million, down 25.94% from the prior year.
  • Common Equity for Q1 2026 stood at $688.3 million, down from $704.2 million in the prior quarter.
  • Over the last five years, Common Equity for VRNO reached as high as $1.5 billion in Q2 2022 and fell as low as $688.3 million in Q1 2026.
  • Historically, Common Equity has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
  • Across the five-year window, Common Equity soared 6973.1% in 2022 and fell 27.27% in 2025, its largest moves.
  • Year by year, Common Equity stood at $1.3 billion in 2022, then retreated by 7.56% to $1.2 billion in 2023, then decreased by 23.33% to $950.8 million in 2024, then retreated by 25.94% to $704.2 million in 2025, then retreated by 2.25% to $688.3 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were $688.3 million in Q1 2026, $704.2 million in Q4 2025, and $885.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.23 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.90 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 56.13 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.50 Bn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 688.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 688.35 Mn
Dec 31, 2025 704.16 Mn
Sep 30, 2025 885.86 Mn
Jun 30, 2025 927.23 Mn
Mar 31, 2025 941.60 Mn
Dec 31, 2024 950.82 Mn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.22 Bn
Mar 31, 2024 1.24 Bn
Dec 31, 2023 1.24 Bn
Sep 30, 2023 1.31 Bn
Jun 30, 2023 1.33 Bn
Mar 31, 2023 1.34 Bn
Dec 31, 2022 1.34 Bn
Sep 30, 2022 1.54 Bn
Jun 30, 2022 1.55 Bn
Dec 31, 2021 1.48 Bn
Sep 30, 2021 42.40 Mn
Jun 30, 2021 21.90 Mn